Non-small cell lung cancer

Clinical practice guidelines in oncology

David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Apar Kishor P. Ganti, Ramaswamy Govindan, Frederic W. Grannis, Leora Horn, Thierry M. Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Feng Ming Kong, Mark G. Kris, Lee M. Krug, Inga T. Lennes & 16 others Billy W. Loo, Renato Martins, Janis O'Malley, Raymond U. Osarogiagbon, Gregory A. Otterson, Jyoti D. Patel, Mary C. Pinder-Schenck, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Eric Rohren, Scott J. Swanson, Douglas E. Wood, Stephen C. Yang, Miranda Hughes, Kristina M. Gregory

Research output: Contribution to journalReview article

245 Citations (Scopus)

Abstract

Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

Original languageEnglish (US)
Pages (from-to)1236-1271
Number of pages36
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number10
DOIs
StatePublished - Oct 1 2012

Fingerprint

Practice Guidelines
Non-Small Cell Lung Carcinoma
Medical Futility
Palliative Care
Therapeutics
Clinical Trials
Guidelines
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Ettinger, D. S., Akerley, W., Borghaei, H., Chang, A. C., Cheney, R. T., Chirieac, L. R., ... Gregory, K. M. (2012). Non-small cell lung cancer: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 10(10), 1236-1271. https://doi.org/10.6004/jnccn.2012.0130

Non-small cell lung cancer : Clinical practice guidelines in oncology. / Ettinger, David S.; Akerley, Wallace; Borghaei, Hossein; Chang, Andrew C.; Cheney, Richard T.; Chirieac, Lucian R.; D'Amico, Thomas A.; Demmy, Todd L.; Ganti, Apar Kishor P.; Govindan, Ramaswamy; Grannis, Frederic W.; Horn, Leora; Jahan, Thierry M.; Jahanzeb, Mohammad; Kessinger, Anne; Komaki, Ritsuko; Kong, Feng Ming; Kris, Mark G.; Krug, Lee M.; Lennes, Inga T.; Loo, Billy W.; Martins, Renato; O'Malley, Janis; Osarogiagbon, Raymond U.; Otterson, Gregory A.; Patel, Jyoti D.; Pinder-Schenck, Mary C.; Pisters, Katherine M.; Reckamp, Karen; Riely, Gregory J.; Rohren, Eric; Swanson, Scott J.; Wood, Douglas E.; Yang, Stephen C.; Hughes, Miranda; Gregory, Kristina M.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 10, No. 10, 01.10.2012, p. 1236-1271.

Research output: Contribution to journalReview article

Ettinger, DS, Akerley, W, Borghaei, H, Chang, AC, Cheney, RT, Chirieac, LR, D'Amico, TA, Demmy, TL, Ganti, AKP, Govindan, R, Grannis, FW, Horn, L, Jahan, TM, Jahanzeb, M, Kessinger, A, Komaki, R, Kong, FM, Kris, MG, Krug, LM, Lennes, IT, Loo, BW, Martins, R, O'Malley, J, Osarogiagbon, RU, Otterson, GA, Patel, JD, Pinder-Schenck, MC, Pisters, KM, Reckamp, K, Riely, GJ, Rohren, E, Swanson, SJ, Wood, DE, Yang, SC, Hughes, M & Gregory, KM 2012, 'Non-small cell lung cancer: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 10, no. 10, pp. 1236-1271. https://doi.org/10.6004/jnccn.2012.0130
Ettinger, David S. ; Akerley, Wallace ; Borghaei, Hossein ; Chang, Andrew C. ; Cheney, Richard T. ; Chirieac, Lucian R. ; D'Amico, Thomas A. ; Demmy, Todd L. ; Ganti, Apar Kishor P. ; Govindan, Ramaswamy ; Grannis, Frederic W. ; Horn, Leora ; Jahan, Thierry M. ; Jahanzeb, Mohammad ; Kessinger, Anne ; Komaki, Ritsuko ; Kong, Feng Ming ; Kris, Mark G. ; Krug, Lee M. ; Lennes, Inga T. ; Loo, Billy W. ; Martins, Renato ; O'Malley, Janis ; Osarogiagbon, Raymond U. ; Otterson, Gregory A. ; Patel, Jyoti D. ; Pinder-Schenck, Mary C. ; Pisters, Katherine M. ; Reckamp, Karen ; Riely, Gregory J. ; Rohren, Eric ; Swanson, Scott J. ; Wood, Douglas E. ; Yang, Stephen C. ; Hughes, Miranda ; Gregory, Kristina M. / Non-small cell lung cancer : Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2012 ; Vol. 10, No. 10. pp. 1236-1271.
@article{6f6972118bce48528e2bc735f13e9528,
title = "Non-small cell lung cancer: Clinical practice guidelines in oncology",
abstract = "Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.",
author = "Ettinger, {David S.} and Wallace Akerley and Hossein Borghaei and Chang, {Andrew C.} and Cheney, {Richard T.} and Chirieac, {Lucian R.} and D'Amico, {Thomas A.} and Demmy, {Todd L.} and Ganti, {Apar Kishor P.} and Ramaswamy Govindan and Grannis, {Frederic W.} and Leora Horn and Jahan, {Thierry M.} and Mohammad Jahanzeb and Anne Kessinger and Ritsuko Komaki and Kong, {Feng Ming} and Kris, {Mark G.} and Krug, {Lee M.} and Lennes, {Inga T.} and Loo, {Billy W.} and Renato Martins and Janis O'Malley and Osarogiagbon, {Raymond U.} and Otterson, {Gregory A.} and Patel, {Jyoti D.} and Pinder-Schenck, {Mary C.} and Pisters, {Katherine M.} and Karen Reckamp and Riely, {Gregory J.} and Eric Rohren and Swanson, {Scott J.} and Wood, {Douglas E.} and Yang, {Stephen C.} and Miranda Hughes and Gregory, {Kristina M.}",
year = "2012",
month = "10",
day = "1",
doi = "10.6004/jnccn.2012.0130",
language = "English (US)",
volume = "10",
pages = "1236--1271",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "10",

}

TY - JOUR

T1 - Non-small cell lung cancer

T2 - Clinical practice guidelines in oncology

AU - Ettinger, David S.

AU - Akerley, Wallace

AU - Borghaei, Hossein

AU - Chang, Andrew C.

AU - Cheney, Richard T.

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Demmy, Todd L.

AU - Ganti, Apar Kishor P.

AU - Govindan, Ramaswamy

AU - Grannis, Frederic W.

AU - Horn, Leora

AU - Jahan, Thierry M.

AU - Jahanzeb, Mohammad

AU - Kessinger, Anne

AU - Komaki, Ritsuko

AU - Kong, Feng Ming

AU - Kris, Mark G.

AU - Krug, Lee M.

AU - Lennes, Inga T.

AU - Loo, Billy W.

AU - Martins, Renato

AU - O'Malley, Janis

AU - Osarogiagbon, Raymond U.

AU - Otterson, Gregory A.

AU - Patel, Jyoti D.

AU - Pinder-Schenck, Mary C.

AU - Pisters, Katherine M.

AU - Reckamp, Karen

AU - Riely, Gregory J.

AU - Rohren, Eric

AU - Swanson, Scott J.

AU - Wood, Douglas E.

AU - Yang, Stephen C.

AU - Hughes, Miranda

AU - Gregory, Kristina M.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

AB - Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

UR - http://www.scopus.com/inward/record.url?scp=84870996017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870996017&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2012.0130

DO - 10.6004/jnccn.2012.0130

M3 - Review article

VL - 10

SP - 1236

EP - 1271

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 10

ER -